Skip to main content
Log in

Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastric acid secretion in response to a protein meal and to exogenously administered synthetic human gastrin 17-I was measured in patients with Barrett's esophagus, patients with uncomplicated gastroesophageal reflux, and normal age- and sex-matched controls. Acid secretion, both basally and in response to gastrin 17-I, was significantly greater in patients with Barrett's esophagus compared to normal individuals without reflux. Basal gastrin levels and meal-stimulated levels of the hormone were similar among all three groups. Sensitivity to gastrin, expressed as the concentration causing half-maximal acid secretion, was also similar among the study groups. It is speculated that elevated basal acid production in Barrett's esophagus may contribute to the pathogenesis of the disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Spechler JS, Goyal RK: Barrett's esophagus. N Engl J Med 315:362–371, 1986

    PubMed  Google Scholar 

  2. Cameron AJ, Ott BJ, Payne WS: The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 313:857–859, 1985

    PubMed  Google Scholar 

  3. Naef AP, Savary M, Ozello L: Columnar-lined lower esophagus: An acquired lesion with malignant predisposition: Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 70:826–835, 1975

    PubMed  Google Scholar 

  4. Spechler SJ, Robbins AH, Rubins HB: Adenocarcinoma and Barrett's esophagus: An overrated risk? Gastroenterology 87:927–933, 1984

    PubMed  Google Scholar 

  5. Sjogren RW Jr, Johnson LF: Barrett's esophagus: a review. Am J Med 74:313–321, 1983

    PubMed  Google Scholar 

  6. Iascone C, DeMeester TR, Little AG, Skinner DB: Barrett's esophagus: Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 118:543–549, 1983

    PubMed  Google Scholar 

  7. Holloway RH, Dobbs WJ: Esophageal motor function in Barrett's esophagus.In Barrett's Esophagus: Pathophysiology, Diagnosis, and Management. SJ Spechler, RK Goyal (eds). New York, Elsevier Science, 1985, pp 105–112

    Google Scholar 

  8. Meyer W, Vollmar F, Bar W. Barrett-esophagus following total gastrectomy: A contribution to its pathogenesis. Endoscopy 11:121–126, 1979

    PubMed  Google Scholar 

  9. Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS: Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93:1–11, 1987

    PubMed  Google Scholar 

  10. Maxwell V, Eysselein VE, Kleibeuker J, Reedy T, Walsh JH: Glucose perfusion intragastric titration. Dig Dis Sci 29:321–326, 1984

    PubMed  Google Scholar 

  11. Johnson LF, DeMeester TR: Twenty-four hour pH monitoring of the distal esophagus: A quantitative measure of gastroesophageal reflux. Gastroenterology 63:325–332, 1974

    Google Scholar 

  12. George JD: New clinical method for measuring the rate of gastric emptying: The double sampling test meal. Gut 9:237–242, 1968

    PubMed  Google Scholar 

  13. Rosenquist GL, Walsh JH: Radioimmunoassay of gastrin.In Gastrointestinal Hormones. Jerzy Glass (ed). New York, Raven Press, 1980, pp 769–795

    Google Scholar 

  14. Blair AJ, Richardson CT, Walsh JH, Chew P, Feldman M: Effect of parietal cell vagotomy on acid secretory responsiveness to circulating gastrin in humans: Relationship to postprandial serum gastrin concentration. Gastroenterology 90:1001–1007, 1986

    PubMed  Google Scholar 

  15. Halvorsen JF, Semb BKH: The Barrett syndrome (the columnar-lined lower esophagus): An acquired condition secondary to reflux esophagitis, a case report with discussion of pathogenesis. Acta Chir Scand 141:683–687, 1985

    Google Scholar 

  16. Bremner CG, Lynch VP, Ellis FH Jr: Barrett's esophagus: Congenital or acquired?: An experimental study of esophageal regeneration in the dog. Surgery 68:209–216, 1970

    PubMed  Google Scholar 

  17. Hamilton SR: Pathogenesis of columnar cell-lined (Barrett's) esophagus.In Barrett's Esophagus: Pathophysiology, Diagnosis, and Management. SJ Spechler, RK Goyal (eds). New York, Elsevier Science, 1985, pp 29–37

    Google Scholar 

  18. Wesdorp ICE, Bartelsman J, Schipper MEI, Tytgat GN: Effect of long-term treatment with cimetidine and antacids in Barrett's oesophagus. Gut 22:724–727, 1981

    PubMed  Google Scholar 

  19. Castell DO: Medical management of the patient with Barrett's esophagus.In Barrett's Esophagus: Pathophysiology, Diagnosis, and Management. SJ Spechler, RK Goyal (eds). New York, Elsevier Science, 1985, pp 199–209

    Google Scholar 

  20. Patel GK, Clift SA, Schaefer RA, Read RC, Texter EC Jr: Resolution of severe dysplastic changes with regression of columnar epithelium in Barrett's esophagus on medical treatment. Gastroenterology 82:1147, 1982

    Google Scholar 

  21. Saltzman M, Barwick K, McCallum RW: Profession of cimetidine-treated reflux esophagitis into a Barrett's stricture. Dig Dis Sci 27:181–186, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Study supported by Smith, Kline, and French, Inc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mulholland, M.W., Reid, B.J., Levine, D.S. et al. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Digest Dis Sci 34, 1329–1334 (1989). https://doi.org/10.1007/BF01538064

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01538064

Key words

Navigation